CRNX Crinetics Pharmaceuticals, Inc.
Healthcare$36.78-0.05%ClosedMarket Cap: $3.88B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$85.83
Target (Median)
$85.50
Target Range
$67.00 - $105.00
Upside from current price: 133.4%
Rating Distribution
3 Strong Buy12 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-15 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2026-05-11 | Oppenheimer | maintain | Outperform | Outperform |
| 2026-05-08 | Citizens | maintain | Market Outperform | Market Outperform |
| 2026-03-02 | Citizens | maintain | Market Outperform | Market Outperform |
| 2026-01-12 | Goldman Sachs | upgrade | Buy | Neutral |
| 2026-01-08 | Citizens | maintain | Market Outperform | Market Outperform |
| 2026-01-06 | Morgan Stanley | maintain | Overweight | Overweight |
| 2025-11-07 | Citizens | maintain | Market Outperform | Market Outperform |
| 2025-09-30 | Oppenheimer | maintain | Outperform | Outperform |
| 2025-09-29 | Leerink Partners | maintain | Outperform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-4.21 | $173.1M | 9 |
| Sun Dec 31 | $-2.28 | $420.5M | 5 |
| Mon Dec 31 | $0.98 | $916.4M | 1 |
| Tue Dec 31 | $4.54 | $1.56B | 1 |